BIOGEN INC. Gain (Loss) on Investments
BIOGEN INC. (BIIB) reported Gain (Loss) on Investments of $15.06 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-03.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2012-02-03
- BIOGEN INC. gain (loss) on investments for the quarter ending 2011-12-31 was -$318.00K, a 252.88% decline year-over-year.
- BIOGEN INC. gain (loss) on investments for the quarter ending 2011-09-30 was -$159.00K, a 103.30% decline year-over-year.
- BIOGEN INC. gain (loss) on investments for the quarter ending 2011-06-30 was -$358.00K, a 105.67% decline year-over-year.
- BIOGEN INC. gain (loss) on investments for the quarter ending 2011-03-31 was $15.90M, a 218.90% increase year-over-year.
- BIOGEN INC. gain (loss) on investments for fiscal 2011 was $15.06M, a 7.71% decline from fiscal 2010.
- BIOGEN INC. gain (loss) on investments for fiscal 2010 was $16.32M, a 31.92% decline from fiscal 2009.
- BIOGEN INC. gain (loss) on investments for fiscal 2009 was $23.97M.
- BIOGEN INC. gain (loss) on investments for fiscal 2008 was -$1.08M.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 3 month as first filed | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 6 month as first filed | Gain (Loss) on Investments 9 month | Gain (Loss) on Investments 9 month as first filed | Gain (Loss) on Investments 12 month | Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2011-12-31 | -$318.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | -$477.00K derived: sum of 2 quarters · filed 2012-02-03 | -$835.00K derived: sum of 3 quarters · filed 2012-02-03 | $15.06M 10-K · filed 2012-02-03 | ||||
| 2011-09-30 | -$159.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | -$517.00K derived: sum of 2 quarters · filed 2011-10-28 | $15.38M 10-Q · filed 2011-10-28 | $15.59M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2011-06-30 | -$358.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | $15.54M 10-Q · filed 2011-07-26 | $15.75M derived: sum of 3 quarters · filed 2012-02-03 | $20.56M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2011-03-31 | $15.90M 10-Q · filed 2011-04-21 | $16.11M derived: sum of 2 quarters · filed 2012-02-03 | $20.92M derived: sum of 3 quarters · filed 2012-02-03 | $27.23M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $5.02M derived: sum of 2 quarters · filed 2012-02-03 | $11.34M derived: sum of 3 quarters · filed 2012-02-03 | $16.32M 10-K · filed 2012-02-03 | ||||
| 2010-09-30 | $4.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $11.13M derived: sum of 2 quarters · filed 2011-10-28 | $16.11M 10-Q · filed 2011-10-28 | $22.90M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | $6.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-26 | $11.30M 10-Q · filed 2011-07-26 | $18.09M derived: sum of 3 quarters · filed 2012-02-03 | $19.84M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | $4.99M 10-Q · filed 2011-04-21 | -$4.99M 10-Q · filed 2010-04-20 | $11.77M derived: sum of 2 quarters · filed 2012-02-03 | $13.53M derived: sum of 3 quarters · filed 2012-02-03 | $33.27M derived: sum of 4 quarters · filed 2012-02-03 | |||
| 2009-12-31 | $6.79M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $8.54M derived: sum of 2 quarters · filed 2012-02-03 | $28.29M derived: sum of 3 quarters · filed 2012-02-03 | $23.97M 10-K · filed 2012-02-03 | -$23.97M 10-K · filed 2010-02-09 | |||
| 2009-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-26 | $21.50M derived: sum of 2 quarters · filed 2010-10-26 | $17.18M 10-Q · filed 2010-10-26 | -$17.18M 10-Q · filed 2009-10-21 | $12.33M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-06-30 | $19.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-20 | $15.43M 10-Q · filed 2010-07-20 | -$15.43M 10-Q · filed 2009-07-17 | $10.58M derived: sum of 3 quarters · filed 2011-02-04 | $20.28M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-03-31 | -$4.31M 10-Q · filed 2010-04-20 | -$9.16M derived: sum of 2 quarters · filed 2011-02-04 | $537.00K derived: sum of 3 quarters · filed 2011-02-04 | |||||
| 2008-12-31 | -$4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $4.85M derived: sum of 2 quarters · filed 2011-02-04 | -$1.08M 10-K · filed 2011-02-04 | $1.08M 10-K · filed 2010-02-09 | ||||
| 2008-09-30 | $9.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | $3.77M 10-Q · filed 2009-10-21 | ||||||
| 2008-06-30 | -$5.93M 10-Q · filed 2009-07-17 | |||||||
| 2007-12-31 | -$16.73M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |